Background: CCR5 is a CC chemokine receptor involved in the migration of effector leukocytes including macrophages, NK, and T cells into inflamed tissues. Also, the role of CCR5 in CD4 + Foxp3 + regulatory T cell (Treg) homing has recently begun to grab attention. Japanese encephalitis (JE) is defined as severe neuroinflammation of the central nervous system (CNS) following infection with mosquito-borne flavivirus JE virus. However, the potential contribution of CCR5 to JE progression via mediating CD4 + Foxp3 + Treg homing has not been investigated.
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Background
The Flavivirus genus, which includes mosquito-borne dengue virus, Japanese encephalitis (JE) virus, and West Nile virus (WNV) [1] [2] [3] , is associated with significant morbidity and mortality due to fatal hemorrhagic fever and encephalitis. Of the flaviviruses, Japanese encephalitis virus (JEV) continues to be the leading cause of viral encephalitis in Asia and the Western Pacific. It poses an increasing threat to global health and welfare, with approximately 67,900 reported cases annually [4] . Due to rapid changes in climate and demography, JEV is currently spreading to previously unaffected regions such as Indonesia, Pakistan, and northern Australia [5] . The incubation period of JEV ranges from 5 to 15 days and is fatal in 25 to 30 % cases, mostly in infants, and a high proportion of patients who survive have serious neurological and psychiatric sequelae [4] , for which JE is considered to be more fatal than WNV encephalitis, resulting in 3-5 % mortality (1100 death/29,000 symptomatic infections) [6] . Pathologically, JE is a severe neuroinflammation in the central nervous system (CNS) closely associated with the disruption of the blood-brain barrier (BBB) [7] . Although little is known about the pathogenesis of JEV, considerable progress has been made in murine models [8, 9] . While JEV infects and kills neurons directly in the CNS, CNS invasion of JEV causes the stimulation of microglia/glia and infiltrated leukocytes, leading to indirect neuronal killing via oversecreting pro-inflammatory cytokines (such as IL-6 and TNF-α) and soluble mediators that can induce neuronal death [10, 11] . This notion implies that JE is an immunopathological disease caused by uncontrolled overactivation of innate and adaptive immune cells, resulting in neurological disorders in the CNS. Therefore, adequate CNS infiltration and activation of peripheral immune cells is considered to play a critical role in protecting hosts from viral encephalitis such as JE. Indeed, CNS infiltration and activation of peripheral leukocytes during JE can cause profound damage if the reaction is excessive or inappropriate [12] . Therefore, balanced CNS infiltration and activation of peripheral leukocytes should be achieved to have a favorable prognosis of JE without tissue injury. Chemokine-mediated influx of peripheral leukocytes into the CNS is believed to clear infection, but also be responsible for deleterious bystander neuronal damage associated with morbidity and, in some cases, increased mortality. For example, CXCR3-deficient mice are found to have enhanced CNS viral titers and mortality following WNV infection [13] , while these mice are protected from lethal infection of lymphocytic choriomeningitis virus (LCMV) or cerebral malaria [14, 15] , suggesting that the final outcome of encephalitis will depend on the nature of the pathogen and a range of host factors. Likewise, CCR5 plays a critical role in recovery from flavivirus encephalitis via appropriate CNS migration of peripheral leukocytes, including NK cells and CD4 + /CD8 + T cells [16] [17] [18] . Indeed, the important role of CCR5 in human host responses to WNV encephalitis was demonstrated by a retrospective cohort study involving persons homozygous for CCR5Δ32 [19] , a loss-of-function mutation found in 1-2 % of Caucasians [20] . Compared to individuals without the mutation, persons carrying a homozygous CCR5Δ32 allele have an increased risk of symptomatic WNV infection. In view of the large number of human infections caused by flaviviruses and their global distribution, there are concerns about the potential adverse outcomes of CCR5 antagonist use for incurable infectious diseases, including human immunodeficiency virus (HIV).
Furthermore H-2 b ), which co-express EGFP and regulatory T cellspecific transcription factor Foxp3 under the control of an endogenous promoter, were obtained from Jackson Laboratories (Bar Harbor, ME). Ccr5 −/− ·Foxp3 GFP mice were generated by crossing Ccr5 −/− mice with Foxp3 GFP knock-in mice. All mice were genotyped and bred in the animal facilities of Chonbuk National University.
Cells, viruses, antibodies, and reagents JEV Beijing-1 strain was obtained from the Green Cross Research Institute (Suwon, Korea) and propagated in a mosquito cell line (C6/36) using DMEM supplemented with 2 % fetal bovine serum (FBS), penicillin (100 U/ml), and streptomycin (100 U/ml) [27] . C6/36 cells were infected with JEV Beijing-1 at a multiplicity of infection (MOI) of 0.1 and incubated in a humidified CO 2 incubator at 28°C for 1 h. After absorption, the inoculum was removed and 7 ml of maintenance medium containing 2 % FBS was added. At approximately 6-7 days postinfection (dpi) Quantitative real-time RT-PCR for determination of viral burden and cytokine expression Viral burden and the expression of cytokines (IL-1β, IL-6, IL-10, IL-17, IFN-γ) and chemokines (CCL2, CCL3, CCL4, CCL5, CXCL1, CXCL2) in inflammatory and lymphoid tissues were determined using quantitative SYBR Greenbased real-time RT-PCR (real-time qRT-PCR). Mice were intraperitoneally (i.p.) infected with JEV (3.0 × 10 7 pfu). Tissues including brain and spleen were harvested at 3, 4, 5, and 7 dpi following extensive cardiac perfusion with Hank's balanced salt solution (HBSS). Total RNAs were extracted from tissues using easyBLUE (iNtRON, Inc., Daejeon, Korea). Reverse transcription of total RNAs was performed using High-Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Foster, CA). These complementary DNAs (cDNAs) were used for real-time qPCR using a CFX96 Real-Time PCR Detection system (Bio-Rad Laboratories, Hercules, CA). The reaction mixture contained 2 μl of template cDNA, 10 μl of 2× SYBR Primix Ex Taq, and 200-nM primers at a final volume of 20 μl. The reactions were denatured at 95°C for 30 s and then subjected to 45 cycles of 95°C for 5 s and 60°C for 20 s. After the reaction cycle was completed, the temperature was increased from 65 to 95°C at a rate of 0.2°C/15 s, and the fluorescence was measured every 5 s to construct a melting curve. A control sample containing no template DNA was run with each assay, and all determinations were performed at least in duplicates to ensure reproducibility. The authenticity of amplified product was determined by melting curve analysis. Viral RNA burden in infected samples was expressed as viral RNA copies per microgram of RNA. The expression levels of cytokines and chemokines were normalized to β-actin. All data were analyzed using Bio-Rad CFX Manager version 2.1 analysis software (Bio-Rad Laboratories).
Infiltrated leukocyte analysis in the CNS
Mice infected with JEV were perfused with 30 ml of HBSS at 3, 5, and 7 dpi via cardiac puncture of the left ventricle. The brains were harvested and homogenized by gently pressing them through 100-mesh tissue sieves, after which they were digested with 25 μg/ml of collagenase type IV (Worthington Biochem, Freehold, NJ), 0.1 μg/ml trypsin inhibitor Nα-p-tosyl-L-lysine chloromethyl ketone, 10 μg/ml DNase I (Amresco, Solon, OH), and 10 mM HEPE in HBSS at 37°C for 1 h with shaking. Cells were separated using Optiprep density gradient (18/10/5 %) centrifugation at 800×g for 30 min (Axis-Shield, Oslo, Norway), after which cells collected from the 18 to 10 % interface were washed twice with PBS. Cells were then counted and stained for CD11b, Ly6G, Ly6C, CD45, F4/80, CD3, CD4, CD8, and NK1.1 using directly conjugated antibodies (eBioscience) at 4°C for 30 min. Finally, these cells were fixed with 10 % formaldehyde. Data collection and analysis were performed with a FACS Calibur flow cytometer (Becton Dickson Medical Systems, Sharon, MA) and the FlowJo (Tree Star, San Carlos, CA) software, respectively.
Analysis and activation of NK cells
The activity of NK cells was assessed by their capacity to produce IFN-γ following brief stimulation with PMA and ionomycin (Sigma-Aldrich). Briefly, splenocytes were prepared from Ccr5 +/+ and Ccr5 −/− mice at 2 dpi and stimulated with PMA and ionomycin (PMA at 50 ng/ml, ionomycin at 750 ng/ml) in the presence of monensin (2 μM) to induce the expression of IFN-γ for 1 h. After stimulation, cells were surface-stained with FITC-antimouse-CD3ε, PE-Cy7 anti-mouse NK1.1, biotin-conjugated anti-mouse pan-NK cells (CD49b) [DX5] antibodies, and streptavidin-APC at 4°C for 30 min. Cells were then washed twice with FACs buffer containing monensin. After fixation, cells were permeabilized with 1× permeabilization buffer (eBioscience) and stained intracellularly with PE anti-mouse IFN-γ (XMF1.2) antibody in permeabilization buffer at room temperature for 30 min. After cells were washed with PBS twice, analysis was performed using a FACS Calibur flow cytometer and FlowJo software.
JEV-specific CD4
+ and CD8 + T cell responses
To monitor CD4 + and CD8 + T cell responses specific for JEV, surviving mice were sacrificed at 7 dpi and splenocytes [28, 29] . Monensin (2 μM) was added to the antigenstimulated cells 6 h before harvest. Cells were washed with PBS twice and surface-stained with FITC-anti-CD4 or CD8 antibodies at 4°C for 30 min, followed by washing twice with PBS containing monensin. After fixation, cells were washed twice with permeabilization buffer and stained with PE-anti-IFN-γ and APC-anti-TNF-α antibodies in permeabilization buffer at room temperature for 30 min. Finally, cells were washed twice with PBS and fixed using fixation buffer. Samples were analyzed using a FACS Calibur flow cytometer and FlowJo software.
Intracellular staining for analysis of CD4 + Th1, Th17, and
Treg cells
To monitor CD4 + Th subsets, mice were infected i.p. with 3.0 × 10 7 pfu of JEV and sacrificed at 3 and 5 dpi. Brain leukocytes and splenocytes were prepared and cultured in 96-well plates (10 6 cells/well) with PMA/ionomycin (Th1 and Th17) in the presence of monensin (2 μM) at 37°C for 5 h. Stimulated cells were washed twice with PBS and surface-stained with FITC-anti-CD4 at 4°C for 30 min. After washing twice with PBS containing monensin and fixation, cells were washed twice with permeabilization buffer (eBioscience, SanDiego, CA) and then stained with PerCP-anti-IFN-γ and APC-anti-IL-17α in permeabilization buffer at room temperature for 30 min. After washing twice with PBS, cells were fixed with fixation buffer. To monitor Treg cells, brain leukocytes and splenocytes were surface-stained with FITCanti-CD4 markers on ice for 30 min, followed by fixation with permeabilization concentrate buffer (eBioscience, sSan Diego, CA) at 4°C for 6 h. After fixation, cells were washed twice with permeabilization and stained with PEanti-Foxp3 in permeabilization buffer at room temperature for 30 min. Sample analysis was performed with a FACS Calibur flow cytometer. 
Foxp3
GFP Tregs were detected by intracellular IL-10 staining combined with surface staining with CCR5 and CD4.
Statistical analysis
All data are expressed as averages ± standard deviation. Statistically significant differences between groups were analyzed using an unpaired two-tailed Student's t test for leukocyte population analysis and in vitro experiments or ANOVA and post hoc testing for multiple comparisons of the means. The significance of differences in viral burden and in vivo cytokine gene expression was evaluated by Mann-Whitney test or unpaired two-tailed Student's t test. Kaplan-Meier survival curves were analyzed using the logrank test. A p value ≤0.05 was considered to indicate statistical significance. All data were analyzed using the Prism software (GraphPad Prism 4, San Diego, CA).
Results

CCR5 is essential for protection against JE but dispensable for control of viral replication
The chemokine receptor CCR5 is believed to play a critical role in recovery from flavivirus encephalitis via efficient leukocyte trafficking to the brain [16] [17] [18] . CCR5 is also a key mediator to recruit CD4 +
Foxp3
+ Tregs known as regulatory CD4 + T cell subset to dampen exacerbated inflammation such as viral encephalitis [21] [22] [23] [24] . Although the role of CD4 mice were infected with JEV, surviving mice were monitored until 15 dpi (Fig. 1a) . Mice in both groups showed similar clinical signs, starting with generalized piloerection, paresis, and rigidity and followed by progression into severe neurological signs such as postural imbalance, ataxia, and generalized tonic-clonic seizure from 4 to 6 dpi. However, CCR5 ablation resulted in marked increases in mortality after showing neurological disorders, with a mortality rate of 100 % for Ccr5 −/− mice vs. 54 % for Ccr5 +/+ mice after JEV infection (3.0 × 10 7 pfu). Likewise, Ccr5
−/− mice showed a rapid increase in the frequency of neurological disorder starting from 3 to 4 dpi after JEV infection (3.0 × 10 7 pfu) with greater body weight loss, compared to Ccr5 +/+ mice (Fig. 1b, c) . However, the viral burden in the extraneural lymphoid tissue (spleen) and CNS (brain and spinal cord) of Ccr5 −/− mice was not increased compared to that of Ccr5 +/+ mice (Fig. 1d ). Therefore, these results indicate that CCR5 ablation could result in an increased susceptibility to JE progression irrespective of viral replication.
CCR5 ameliorates JE progression
To further characterize CNS inflammation caused by JEV infection in Ccr5 +/+ and Ccr5 −/− mice, we assessed the infiltration of CD11b + Ly-6C hi monocytes and CD11b + Ly-6G hi granulocytes into CNS, because infiltration of these cell populations derived from the myeloid cell lineage has been used to evaluate CNS inflammation [30] . Our results revealed that a markedly higher frequency of infiltrated CD11b + Ly-6C hi monocytes and CD11b + Ly-6G hi granulocytes was retained in the brain of Ccr5 −/− mice at 3, 5, and 7 dpi, compared to that in the brain of Ccr5 +/+ mice ( Fig. 2a) . Similarly, the absolute number of CD11b + Ly-6C hi monocytes and CD11b + Ly-6G hi granulocytes infiltrating the brain of Ccr5 −/− mice was increased two-and threefold at 5 dpi, respectively (Fig. 2b) . Moreover, microglia cells contribute to the progression of encephalitis caused by some neurotropic viruses, such as WNV [31, 32] . Thus, four-color (CD11c/CD11b/CD45/F4/80) staining was used to distinguish resting from activated microglia. Based on the CNS myeloid cell classification method of Ford et al. [33] , equivalent percentages and similar absolute numbers of resting microglia (CD11c −/− mice (4 to 6 weeks old, n = 10-15) was inoculated i.p. with JEV (3.0 × 10 7 pfu). The survival rate was examined over 15 days. b Ratio of mice showing neurological disorders during JE progression. Mice infected with JEV were examined every 6 h from 4 to 8 dpi. c Changes in body weight. Data are average percentages ± SD of body weight relative to that at the time of challenge. d Viral burden in lymphoid and inflammatory tissues during JE. Viral burden in lymphoid (spleen) and inflammatory tissues (brain and spinal cord) of infected mice (n = 5-6) were assessed by real-time qRT-PCR at the indicated time points. Viral RNA load was expressed as viral RNA copy number per microgram of total RNA (n = 5-7). *p < 0.05; **p < 0.01 compared to the levels in the corresponding groups inflammatory monocytes and granulocytes in the CNS, along with activation of microglia. CCR5 is also considered to be involved in the recruitment of lymphoid lineagederived cells, including CD4 + , CD8 + T cells, and NK cells [34, 35] , which may play a beneficial role in the control of JE progression [36] [37] [38] mice was comparable at 5 and 7 dpi. This result implies that CD4 + T and NK cells might not predominate in the control of JE that has already progressed, because infected mice usually showed clinical signs at around 4-5 dpi.
However, CD8
+ T cells infiltrated the brain of Ccr5 −/− mice at gradually increased levels up to 5 dpi compared to that in the brain of Ccr5 +/+ mice (Fig. 2e) , indicating that enhanced infiltration of CD8 + T cells is closely associated with JE progression.
In terms of CNS inflammation, the expression of cytokines and chemokines within the CNS is required for encephalitis, because encephalitis caused by neurotropic viruses is indirectly derived from CNS degeneration, due to robust immunological responses such as uncontrolled secretion of cytokines and chemokines, which results in the activation of microglia and astrocytes [10, 11] . Therefore, we examined the expression of cytokines and chemokines in the CNS. We found that CCR5 ablation resulted in early and increased expression of pro-and anti-inflammatory T cells in the CNS were enumerated using flow cytometric analysis at 3, 5, and 7 dpi. Data are averages ± SD of the indicated cell populations derived from at least three independent experiments (n = 4-5). *p < 0.05; **p < 0.01; ***p < 0.001 compared with the levels of the indicated groups cytokines at 3 dpi. However, IFN-γ expression was higher in Ccr5 +/+ mice at 3 dpi, compared to in Ccr5 −/− mice. The early increase in CNS infiltration of CD4 + and NK cells likely led to earlier and higher expression of IFN-γ. In addition, it was interesting that the expression levels of some cytokines were reversed at 5 dpi (Fig. 3a) . Notably, the anti-inflammatory cytokine IL-10 was expressed at higher levels in Ccr5 +/+ mice at 5 dpi, whereas IL-17, which is produced by CD4 + Th17 cells, was expressed at a lower level in Ccr5 +/+ mice compared to those in Ccr5 −/− mice at 5 dpi. With regard to chemokine expression, CC chemokines were expressed at higher levels in Ccr5 −/− mice 4 dpi compared to those in Ccr5 +/+ mice. Interestingly, the expression levels of CXC chemokines, CXCL1 and CXCL2, were enhanced in Ccr5 −/− mice at 3 dpi, and such expression was reversed at 5 dpi (Fig. 3b) . Collectively, these results indicate that the expression levels of pro-/antiinflammatory cytokines and CC/CXC chemokines in the CNS of Ccr5 +/+ and Ccr5 −/− mice could change dynamically depending on the progression of JE.
Kinetic analysis of myeloid and lymphoid cells in the spleen and blood of CCR5-ablated mice
Because the CNS expression pattern of CC and CXC chemokines in Ccr5 +/+ and Ccr5 −/− mice differed according to JE progression, this CC/CXC chemokine expression may affect the migration of myeloid and lymphoid cells, including monocytes, granulocytes, NK, and T cells in both Ccr5 +/+ and Ccr5 −/− mice. Therefore, to better understand the recruitment of myeloid and lymphoid cells in the CNS, we kinetically examined the number of myeloid and lymphoid cells in the spleen and blood of Ccr5 +/+ and Ccr5 −/− mice depending on JE progression. In addition, analyzing the spleen could provide insight into how CCR5 modulates innate and inflammatory responses immediately after infection. Analysis of myeloid CD11b + and lymphoid CD8α + DC subsets revealed that both Ccr5 +/+ and Ccr5 −/− mice exhibited a similar reduction in the spleen (Fig. 4a) , as wildtype mice have been previously shown to have a transiently decreased number of myeloid and lymphoid DCs due to JEV infection [27] . However, Ccr5 −/− mice had higher numbers of inflammatory CD11b + Ly-6C hi monocytes and Ly-6G hi neutrophil in the spleen up to 5 dpi, compared to Ccr5 +/+ mice (Fig. 4b) , indicating that Ccr5 −/− mice experienced a severe inflammatory reaction in the spleen. Also, the absolute number of splenic CD3 −/− mice (Fig. 4c) . Interestingly, our results revealed that the frequency and number of NK cells producing IFN-γ were increased in Ccr5 −/− mice, rather than in Ccr5 +/+ mice, when the activation of NK cells was evaluated by assessing their production of IFN-γ (Fig. 4d) . These data indicate that NK cells might not be involved in the amelioration of JE in Ccr5 +/+ mice. Furthermore, our results revealed that the number of Ly-6C hi monocytes and Ly-6G hi neutrophils in the blood followed hi monocytes and Ly-6G hi neutrophils in the brain. CCR5-ablated mice had higher numbers of Ly-6C hi monocytes and Ly-6G hi neutrophils in the blood up to 5 dpi, compared to Ccr5 −/− mice (Fig. 4f) . Also, NK cells in the blood of Ccr5 −/− mice were detected at transiently lower levels at the early phase (1 and 2 dpi), after which they were comparable in Ccr5 +/+ and Ccr5 (Fig. 4g) . CD4 + T cell numbers were transiently higher number in the blood of Ccr5 +/+ mice than in Ccr5 −/− mice at 2 and 3 dpi, but CD8 + T cells accumulated to higher levels in Ccr5 −/− mice, rather than Ccr5 +/+ mice, at up to 5 dpi (Fig. 4h) . Therefore, these results suggest that CCR5 ablation is not involved in the migration of myeloid and lymphoid cells from the blood into the brain during JE progression.
Adaptive T cell immune responses in CCR5-ablated mice
Antiviral adaptive immune responses, including those mediated by effector antigen-specific CD4 + and CD8 + T cells, are required for the regulation of JE progression through the control and clearance of JEV in extraneural lymphoid tissues and the CNS [36] [37] [38] . Although both Ccr5 +/+ and Ccr5 −/− mice infected with JEV exhibited neurological disorders at 4-5 dpi, which is before functional adaptive immune responses were fully induced, we examined the generation of JEV-specific CD4 + T cell responses in surviving Ccr5 +/+ and Ccr5 −/− mice at 7 dpi using intracellular CD154 staining combined with intracellular cytokine IFN-γ staining, because CD154 + CD4
+ T cells could enable us to enumerate viable JEV-specific CD4 + T cells in response to stimulation with epitope peptides [28, 29] . As shown in Fig. 5a + /CD8 + T cells (h) were determined using flow cytometric analysis at the indicated time points. Data are averages ± SD of values derived from at least three independent experiments (n = 3-5). *p < 0.05; **p < 0.01; ***p < 0.001 compared to the levels in the corresponding groups stimulation with JEV epitope peptides at 7 dpi, compared to Ccr5 −/− mice (Fig. 5c, d ). Presumably, this increase in IFN-γ + CD4
+ T cells specific for JEV Ag may contribute in part to the control of JE progression in Ccr5 +/+ mice at a later phase. In contrast, the frequency and total number of JEV-specific CD8 + T cells producing IFN-γ and TNF-α in response to stimulation with the CD8 + T cell epitope NS4B 215-223 were higher in Ccr5 −/− mice than in Ccr5 +/+ mice (Fig. 5e, f) . This result was inconsistent with the enhanced CNS infiltration of CD8 + T cells. Taken together, these results suggest that antiviral JEV-specific CD8 + T cells may not be key players in the control of JE progression in Ccr5 +/+ mice at the early phase (4-5 dpi). However, IFN-γ + CD4
+ T cells specific for JEV Ag appear to play a role in the control of JE progression in Ccr5 +/+ mice at the later phase (7-8 dpi). 
Foxp3
+ Tregs at both 3 and 5 dpi, compared to Ccr5 −/− mice (Fig. 6a) . However, Ccr5 −/− mice showed an increased frequency and total number of CD4 + Th1 expressing IFN-γ and CD4 + Th17 expressing IL-17 in the spleen at both 3 and 5 dpi, compared to Ccr5 +/+ mice (Fig. 6b) . This result indicates that Ccr5 + Th1, Th2, Th17, and Tregs was determined by real-time qRT-PCR using total RNA extracted from stimulated CD4 + T cells. Data are averages ± SD of values derived from at least three independent experiments (n = 3-4). *p < 0.05; **p < 0.01; ***p < 0.001 compared with the levels of the indicated groups the early stage of JE progression. To further define the skewed response of the CD4 + Th subsets in Ccr5 −/− mice, we examined CNS-infiltrated CD4 + Th subsets at 3 and 5 dpi during JE progression. Ccr5 +/+ mice showed a rapidly increased frequency and absolute number of CNSinfiltrated CD4 + Foxp3 + Tregs; levels were two-to threefold higher than those of Ccr5 −/− mice (Fig. 6c) . Also, Ccr5
+/+ mice exhibited a moderately increased number, but not frequency, of CD4 + Th1 expressing IFN-γ in the CNS at 3 and 5 dpi, whereas a markedly increased frequency and number of CD4 + Th17 expressing IL-17 were detected in the CNS of Ccr5 −/− mice; being approximately tenfold higher than those of Ccr5 +/+ mice (Fig. 6d) . Moreover, CD4 + T cells sorted from the CNS of Ccr5 +/+ mice showed higher expression of the transcription factors T-bet and Foxp3, which are involved in the differentiation of CD4 + Th1 cells and Tregs, compared to those from the CNS of Ccr5 −/− mice (Fig. 6e) 
GFP mice showed high susceptibility to JE, with a mortality rate of 90 %, similar to that of Ccr5 
+ Treg recipients (Fig. 7b) (Fig. 7d) (Fig. 8a, b) (Fig. 8c) . Similarly, injection of CCR5 + CD4 + Foxp3 GFP Tregs into Ccr5 −/− recipients resulted in a moderate but insignificant increase in the number of CD11b + Ly-6C hi monocytes and CD11b + Ly-6G hi granulocytes in the CNS (Fig. 8d) . This result indicates that CCR5 GFP Tregs was evaluated by intracellular IL-10 staining at 5 dpi. Data are averages ± SD of values derived from at least three independent experiments (n = 3-4). *p < 0.05; **p < 0.01; p < 0.001 compared with the levels of the indicated groups not receive Tregs (Fig. 8e) (Fig. 6d) . Similarly, an increased number of CD4 + Foxp3 + Tregs was observed in the spleen of CCR5 + Treg-injected Ccr5 −/− recipients, compared to that of Ccr5 −/− mice receiving CCR5
− Tregs (Fig. 8g) + Treg frequencies prior to WNV infection, while asymptomatic patients exhibit greater Treg expansion within the first 2 weeks of infection [25] , the proliferation and/or differentiation of CD4 +
+ Tregs in asymptomatic persons seems to be promoted by unknown factors (molecular or cellular components) derived from WNV infection. The expanded Tregs then migrate into inflammatory tissues by means of homing receptors such as CCR5, thereby promoting host survival. In line with this notion, the expansion of CD4 +
+ Tregs in JEV-infected Ccr5 +/+ mice was around two-fold higher at 5 dpi, and the TLR4 signaling pathway is likely to be involved in their expansion in a JE model [27] . Also, the impact of CCR5 in CD4 
+ Tregs may dictate the magnitude of the CD4 + Th1 and/or Th17 subset responses to favor a detrimental or beneficial effect on pathogen persistence at the site of infection [23, 24, 40, 41] . Our results favor a beneficial role for CD4 + Foxp3 + Tregs in ameliorating severe neuroinflammation caused by JEV infection, depending on CCR5-mediated homing to inflammatory tissue. Therefore, CCR5 is involved in the putative role of CD4 + Foxp3 + Tregs in severe flavivirus-induced diseases, such as encephalitis and hemorrhagic fever.
The role of CCR5 in infectious diseases is variable in terms of its impact on pathogenesis and disease outcome. An essential role of CCR5 in ameliorating the outcome of infectious diseases has been documented in trypanosomiasis [42] , toxoplasmosis [43] , genital herpes [44] , influenza [45] , flaviviral West Nile encephalitis, and JE [16] [17] [18] , while a beneficial effect of CCR5 deficiency on the outcome of other infectious diseases has been postulated [23, 24, 39, 46, 47] . Mechanistically, these variable outcomes of CCR5 deficiency in infectious diseases have been largely attributed to its regulatory effect on trafficking of leukocytes, including NK, CD4, CD8, and CD4
+
Foxp3
+ Treg cells to the site of infection as a consequence of the elevated immunopathology. Therefore, this dichotomy in the role of CCR5 in regulating the outcome of infectious diseases prevents the generalization of our findings of the impact of chemokine receptors in disease prognosis. Nevertheless, CCR5 is believed to play a crucial role in protection against severe neuroinflammation caused by flavivirus infections [16] [17] [18] . In this study, we also confirmed an essential role for CCR5 in regulating JE progression. However, CCR5 deficiency failed to alter or increase the viral burden in extraneural tissue (spleen) and the CNS. [17] . The discrepancy might be due to differences in the genetic background and age of the host, strain and dosage of virus, and the route of challenge. Indeed, because Ccr5 +/+ and Ccr5
−/− mice began to show clinical signs, such as neurological disorders, at 3-5 dpi, which is before functional adaptive immune responses were fully induced, the JE model used in this study appeared to have more acute and rapid progression than that in a previous study, in which clinical signs were observed at 8-10 dpi [17] . This accelerated and rapid progression of JE in Ccr5 +/+ and Ccr5 −/− mice might have resulted in induction of distinct NK and CD4/CD8 T cell responses in the host. Early regulation of severe neuroinflammation in the CNS through regulatory mechanisms such as CD4 + Foxp3 + Tregs and myeloidderived suppressor cells (MDSC) may be important for host survival in cases of acute and rapid progression of JE. This notion is strengthened by the result that Ccr5 +/+ and Ccr5 −/− mice showed similar splenic CD4 + and CD8 + immune responses in a WNV infection model, to which mice are highly susceptible compared to humans [16] . Also, the fact that CD4 
Tregs in Ccr5
−/− mice at 3 dpi, the time point at which infected mice began to show clinical signs, such as generalized piloerection, paresis, and rigidity. Although further study is warranted, CCR5 appears to play a non-committed role in JE progression by regulating the trafficking equilibrium of effector leukocytes and regulatory CD4 + Foxp3 + Tregs, depending on disease progression.
It is likely that our results discount the role of CCR5 in ameliorating JE progression by CNS infiltration of effector leukocytes such as NK cells, macrophages, CD4 + cells, and CD8 + T cells. It has long been assumed that leukocyte infiltration into the CNS is critical for clearing virus and aiding recovery. CCR5 deficiency was associated with increased flavivirus burden in the CNS but not in extraneural tissues, which was mechanistically mediated by inappropriate CNS infiltration of leukocytes [16, 17] . However, the critical role of CCR5 in flavivirus pathogenesis appears to be unique in other neurotropic viruses, because infections of Ccr5 −/− mice with several neurotropic viruses, such as LCMV [49] , retrovirus FR98 [50] , and mouse hepatitis virus (MHV) [51] , resulted in viral burdens in the CNS similar to those of Ccr5 +/+ mice. Unlike earlier works on flavivirus encephalitis [16, 17] , the present study showed that the JEV burden in the extraneural tissue and CNS of Ccr5 +/+ mice was similar to that in Ccr5 −/− mice, with transiently and early increased CNS infiltration of NK and CD4 + cells, but not CD8 + T cells, in Ccr5 +/+ mice. Although the mechanisms of increased CNS infiltration of leukocytes in Ccr5 −/− mice with an unchanged viral burden need to be defined, the JE model used appears to affect the dynamics of leukocyte CNS infiltration and the subsequent viral burden. CNS trafficking of Ly-6C hi monocytes and Ly-6G hi granulocytes is mediated through a multistep process governed by CC and CXC chemokines. In support, the enhanced expression of CC chemokines including CCL2, CCL3, CCL4, and CCL5 appeared to facilitate CNS infiltration of Ly-6C hi monocytes in Ccr5 −/− mice at the early phase, although whether these cells function to suppress or promote pathogenesis is unclear [52, 53] . One interesting result in this study was the reversal of CXC chemokine expression between 3 and 5 dpi. Although CXCL1 and CXCL2 play a dominant role in the trafficking of Ly-6G hi granulocytes, CC chemokines are also likely to be involved in CNS infiltration of Ly-6G hi granulocytes [54] . Furthermore, increased CNS infiltration of Ly-6G hi granulocytes in Ccr5 −/− mice is strengthened by the result that CCR5 ablation increases the recruitment of Ly-6G hi granulocytes in herpetic encephalitis [55] . Also, it is conceivable that CXCL2 is involved in the recruitment of granulocytic MDSCs at a later stage [56] , thereby resulting in the amelioration of JE progression. However, CCR5 appeared not to be involved in the migration of myeloid and lymphoid cells from the blood into the brain, because the accumulation of myeloid (monocytes, granulocytes) and lymphoid (NK, CD4/CD8 T cells) cells in the blood showed similar patterns to those in the brain. These data are in line with a previous report that CCR2 is not involved in monocyte migration from the blood into the brain [57] . CCR5 ablation may cause accumulation of CCR5 ligands (CCL3, CCL4, CCL5) via their compensation mechanism [58] , which could induce dysregulation of the migration of monocytes, NK cells, and T cells expressing cognate receptors (CCR1, CCR3). Also, the appropriate adaptive CD4 + and CD8 + T cell responses can be achieved by orchestrated chemokine expression in secondary lymphoid tissues to promote contact between T and dendritic cells [59] . Indeed, our results demonstrate unexpected adaptive JEV-specific CD4 + and CD8 + T cell responses in Ccr5 −/− mice; stronger responses of JEV-specific CD4 + T cells were induced in Ccr5 +/+ mice, whereas Ccr5 −/− mice displayed a potent JEV-specific CD8 + T cell response. Ultimately, these speculations suggest that other chemokine receptors may be involved in the migration of myeloid and lymphoid cells as well as adaptive T cell responses in a CCR5-ablated environment, due to redundancy and compensation of chemokines and their receptors. In addition, the role of NK and CD8 + T cells in CNS clearance of JEV remains elusive, because the depletion or adoptive transfer of NK and CD8 + T cells does not contribute significantly to host survival or viral clearance [36] . Also, although IFN-γ + CD4 + Th1 cells are believed to play a role in regulating JE progression by reducing viral burden in the CNS [38] , only co-transfer of immune CD4 + and CD8 + T cells, not individual transfer of either T cell subpopulation, significantly ameliorates JE progression and promotes host survival [37] . These facts support the possibility that transiently and early increased CNS infiltration of NK and IFN-γ + CD4 + Th1 cells in Ccr5 +/+ mice may not be sufficient for viral clearance from the CNS, resulting in a similar CNS viral burden in Ccr5 +/+ and Ccr5 −/− mice. Therefore, balanced and orchestrated CNS infiltration by innate NK and adaptive T cell subpopulations likely mediates viral clearance, thereby providing protection against JE progression without tissue injury. IL-17 is produced mainly by IL-17 + CD4 + Th17 cells. It plays a critical role in autoimmune and virus-caused immunopathologic diseases by facilitating neutrophil recruitment [60] [61] [62] . In contrast, IL-17 appears to play a minor role in protective immunity against parasitic infection [63] but a more important role in fungal infection in a CCR5-ablated environment [39] . 
CD4
+ Th17 cells has led to speculation that these T cell subsets exist in equilibrium during inflammation and infection [66, 67] . However, this equilibrium was disturbed, thereby causing exacerbation of JE progression in Ccr5 −/− mice. Therefore, our results provide insight into the utility of IL-10 and CD4 [68] . Therefore, understanding the detailed role of CCR5 in the pathogenesis of flavivirus-caused encephalitis will be important to prevent any potential risk to HIV-positive individuals who take CCR5 antagonists with curative intent.
Abbreviations BBB, blood-brain barrier; CCR5, CC chemokine receptor 5; CNS, central nervous system; dpi, days post-infection; HIV, human immunodeficiency virus; JEV, Japanese encephalitis virus; KO, knockout; LCMV, lymphocytic choriomeningitis virus; MDSC, myeloid-derived suppressor cell; Treg, regulatory T cell; WNV, West Nile virus
